In a further study of post-operative glycaemic control in T2DM, Müssig and colleagues randomised patients to GLP-1 (3.6 pmol kg− 1 min− 1) or standard intravenous insulin in the 12 h following CABG [31]. The gene discussed is INS; the disease is type 2 diabetes mellitus.